Home > Riviste > Minerva Urology and Nephrology > Fascicoli precedenti > Minerva Urology and Nephrology 2021 August;73(4) > Minerva Urology and Nephrology 2021 August;73(4):431-41



Opzioni di pubblicazione
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca


Publication history
Per citare questo articolo


REVIEW   Free accessfree

Minerva Urology and Nephrology 2021 August;73(4):431-41

DOI: 10.23736/S2724-6051.21.04330-5


lingua: Inglese

Oncological and functional outcomes of testis sparing surgery in small testicular mass: a systematic review

Vincenzo FAVILLA 1, Rossella CANNARELLA 2 , Antonio TUMMINARO 3, Davide DI MAURO 3, Rosita A. CONDORELLI 2, Sandro LA VIGNERA 2, Vincenzo FICARRA 1, Sebastiano CIMINO 3, Aldo E. CALOGERO 2

1 Section of Urology, Gaetano Barresi Department of Human and Pediatric Pathology, University of Messina, Messina, Italy; 2 Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy; 3 Section of Urology, Department of Surgery, University of Catania, Catania, Italy

INTRODUCTION: The prevalence of testicular tumor is constantly increasing, with an estimated incidence rate of about 3-10 new cases per 100,000 males/per year. Radical orchiectomy or testis sparing surgery (TSS) are recognized therapeutic approaches in these cases. However, the risk for hypogonadism and infertility is higher with the former compared with the latter. The aim of this systematic review is to evaluate the oncological outcome and testicular function (endocrine and reproductive aspects) in patients who had undergone TSS for small testicular lesions.
EVIDENCE ACQUISITION: To accomplish this, 684 articles were retrieved and screened; 24 retrospective and two prospective studies were selected and finally included in this systematic review.
EVIDENCE SYNTHESIS: Overall the TSS attempts were 1096 but TSS was definitively performed in 603 cases (55%). Frozen section examination was performed in 996 TSS attempts (22 out of the 26 studies selected) and showed a benign histology in 37-100% of cases, a malignant histology in 0-63%, and an inconclusive result in 0-16%, respectively. Five studies reported that a total of 22 patients were able to father after conservative surgery. None of these studies reported cases of hypotestosteronemia after surgery and a low prevalence (1.66%) of complications was associated with this type of surgery.
CONCLUSIONS: In conclusion, TSS showed to be safe and practicable if used according to the specific guidelines. It can be safely performed to treat recurrence eventually associated to local adjuvant radiotherapy when an intra-tubular neoplasia is present. Urologists can therefore consider TSS as an important means against testicular tumor in selected and well-informed patients.

KEY WORDS: Testicular neoplasms; Urogenital surgical procedures; Orchiectomy; Fertility preservation; Hypogonadism

inizio pagina